.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Key metrics and characteristics
The county where this buyer is located.
Physical address of this buyer.
Postal code for this buyer's location.
How likely this buyer is to spend on new technology based on operating budget trends.
How likely this buyer is to adopt new AI technologies.
How often this buyer champions startups and early adoption.
Includes fiscal year calendars, procurement complexity scores, and strategic insights.
Synthesizing live web signals with exclusive contracts, FOIA docs, and board-level intelligence.
Ask a question to get started or click a suggestion below.
Search across FDA Office of Acquisition Grant Services's meeting minutes, FOIA documents, procurement records, and public filings. Our AI reads thousands of sources so you don't have to.
Keep your public sector contacts fresh and actionable. No more stale data.
Premium
Win more deals with deep buyer insights
Decision Makers
Head of Contracting Activity; Director, Office of Acquisitions and Grants Services
Director, Division of Policy, Systems and Program Support (DPSPS)
Acting Director, Division of Information Technology Acquisitions (DITA)
Premium
Access the largest public sector contact database
Active opportunities open for bidding
FDA Office of Acquisition Grant Services
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services, issued a sources-sought/market research notice seeking capability statements for a closed-filtration sterility pump compatible with Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pumps. This is market research only (not a request for proposal or a grant) and vendors are asked to email capability statements including country-of-manufacture information to Warren.Dutter@fda.hhs.gov. Submissions were requested by February 2, 2026, and the notice is a single, active sources-sought opportunity for the FDA on behalf of the Irvine Medical Products Laboratory.
Posted Date
Jan 22, 2026
Due Date
Feb 2, 2026
Release: Jan 22, 2026
FDA Office of Acquisition Grant Services
Close: Feb 2, 2026
The U.S. Food and Drug Administration (FDA), Office of Acquisitions and Grant Services, issued a sources-sought/market research notice seeking capability statements for a closed-filtration sterility pump compatible with Millipore-Sigma Steritest Symbio Laminar Flow Hood (LFH) pumps. This is market research only (not a request for proposal or a grant) and vendors are asked to email capability statements including country-of-manufacture information to Warren.Dutter@fda.hhs.gov. Submissions were requested by February 2, 2026, and the notice is a single, active sources-sought opportunity for the FDA on behalf of the Irvine Medical Products Laboratory.
AvailableFDA Office of Acquisition Grant Services
The FDA Office of Acquisition and Grant Services issued a Special Notice announcing its intent to sole source contracts for the 2026 U.S. Human Food Inspection Program to state and territorial governmental organizations to perform regulatory food safety inspections and investigations under the Federal Food, Drug, and Cosmetic Act. The procurement seeks organizations with statutory authority to conduct regulatory inspections, trained inspectional personnel, and experience implementing corrective actions; contracts are expected to include a 12-month base period and four 12-month options. The notice was posted 2026-01-15 with a response deadline of 2026-01-30 and requests statements of capabilities to be submitted via email to the listed FDA contact.
Posted Date
Jan 15, 2026
Due Date
Jan 30, 2026
Release: Jan 15, 2026
FDA Office of Acquisition Grant Services
Close: Jan 30, 2026
The FDA Office of Acquisition and Grant Services issued a Special Notice announcing its intent to sole source contracts for the 2026 U.S. Human Food Inspection Program to state and territorial governmental organizations to perform regulatory food safety inspections and investigations under the Federal Food, Drug, and Cosmetic Act. The procurement seeks organizations with statutory authority to conduct regulatory inspections, trained inspectional personnel, and experience implementing corrective actions; contracts are expected to include a 12-month base period and four 12-month options. The notice was posted 2026-01-15 with a response deadline of 2026-01-30 and requests statements of capabilities to be submitted via email to the listed FDA contact.
AvailableFDA Office of Acquisition Grant Services
2 ea, Aqualab TDL 2 or equivalent instruments.
Posted Date
Jan 16, 2026
Due Date
Jan 23, 2026
Release: Jan 16, 2026
FDA Office of Acquisition Grant Services
Close: Jan 23, 2026
2 ea, Aqualab TDL 2 or equivalent instruments.
Get alerted before the bid drops, know which RFPs to pursue, and generate compliant drafts with AI.
Track vendor wins and renewal opportunities
FDA Office of Acquisition Grant Services
IGF::OT::IGF HP DL380 GEN9 8SFF CTO SERVERS
Effective Date
Jul 19, 2017
Expires
Effective: Jul 19, 2017
FDA Office of Acquisition Grant Services
Expires:
IGF::OT::IGF HP DL380 GEN9 8SFF CTO SERVERS
FDA Office of Acquisition Grant Services
IGF::OT::IGF ROTOR
Effective Date
Aug 22, 2016
Expires
Effective: Aug 22, 2016
FDA Office of Acquisition Grant Services
Expires:
IGF::OT::IGF ROTOR
FDA Office of Acquisition Grant Services
JUNIPER MAINTENANCE RENEWAL
Effective Date
Jan 23, 2023
Expires
Effective: Jan 23, 2023
FDA Office of Acquisition Grant Services
Expires:
JUNIPER MAINTENANCE RENEWAL
See expiring contracts, renewal risk, pricing history, and competitor awards — then sync the data to your CRM.
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}
.avif&w=256&q=75){kind=small}